Clinical Trials Browser

Phase 1/2 × INDUSTRY × gallium maltolate × Clear all

NCT00050687 2011-01-28

Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

Phase 1/2 Terminated

GenitourinaryLymphoidPlasma cell

Urinary Bladder Neoplasms, Lymphoma, Multiple Myeloma, Prostatic Neoplasms